Capecitabine Versus Vinorelbine in High Risk Breast Cancer With Pathologic Residual Tumors After Preoperative Chemotherapy
Clinical trial NCT03703427 · UNKNOWN
Trial details
- NCT number
- NCT03703427
- Sponsor
- Zhiyong Yu
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-01
- Primary completion
- 2023-11-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.